Alyeska Investment Group, L.P. Agios Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $1.27 Million - $2.09 Million	-37,359 Reduced 21.17%	139,132 $4.87 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $2.86 Million - $4.44 Million	82,939 Added 88.66%	176,491 $9.44 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $1.37 Million - $2.33 Million	43,362 Added 86.4%	93,552 $3.32 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $859,114 - $1.44 Million	-28,561 Reduced 36.27%	50,190 $2.4 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $4.3 Million - $6.59 Million	-132,868 Reduced 62.79%	78,751 $2.55 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $2.52 Million - $3.71 Million	54,501 Added 34.69%	211,619 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $3.46 Million - $5.1 Million	75,405 Added 92.28%	157,118 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $3.49 Million - $6.25 Million	81,713 New	81,713 $3.77 Million

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.